세계의 주사 시멘트 시장 : 유형별, 용도별 예측(2025-2030년)

The Injectable Cement Market was valued at USD 1.53 billion in 2023, expected to reach USD 1.61 billion in 2024, and is projected to grow at a CAGR of 5.22%, to USD 2.19 billion by 2030.

Injectable cement is a specialized material used extensively in the medical, dental, and construction industries due to its unique ability to fill voids and set under controlled conditions. Primarily composed of calcium phosphate or related compounds, its necessity stems from its biocompatibility, quick setting time, and ability to form a stable support structure. In medical applications, injectable cement is critical in minimally invasive surgeries, such as vertebroplasty and kyphoplasty, where it restores vertebral stability and alleviates pain. The construction industry uses these materials for tasks requiring precision and durability, such as repairing cracks or anchoring building foundations. The market for injectable cement is driven by technological advancement in surgical procedures, an aging population increasing the prevalence of osteoporosis and related bone disorders, and a demand for rapid, reliable construction solutions.

Recent innovations highlight opportunities for growth, such as the development of biodegradable and bioactive cements, presenting substantial potential for companies willing to invest in research and development. Nanotechnology integration is another promising frontier, offering enhancements in cement properties such as reduced setting times and improved strength and durability. However, the market is constrained by several limitations, including the high cost of innovation, stringent regulatory requirements, and possible side effects or complications in medical applications, such as thermal necrosis. Additionally, competition from alternative materials like polymers and the slow adoption in certain industries due to a lack of awareness impede growth.

To capitalize on these opportunities, companies should focus on developing more cost-effective production methods and investing in educational initiatives to increase awareness of the benefits and applications of injectable cement. Collaborating with healthcare providers and construction firms to customize solutions for specific needs could also drive demand. Continuous research in enhancing material properties while ensuring compliance with regulations will be crucial for sustaining long-term growth in this market, evolving the product offerings, and maintaining competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injectable Cement Market

The Injectable Cement Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing rate of minimally invasive surgeries
  • High risk of bone defects among the geriatric population
  • Growing government investments in the healthcare research
• Market Restraints
  • Limited availability of injectable cement materials
• Market Opportunities
  • Advanced properties of bioactive calcium phosphate bone cement
  • Development of new injectable cement materials
• Market Challenges
  • Severe immune response and infections caused by injectable cement

Porter's Five Forces: A Strategic Tool for Navigating the Injectable Cement Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injectable Cement Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injectable Cement Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injectable Cement Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injectable Cement Market

A detailed market share analysis in the Injectable Cement Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injectable Cement Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injectable Cement Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injectable Cement Market

A strategic analysis of the Injectable Cement Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injectable Cement Market, highlighting leading vendors and their innovative profiles. These include Arthrex, Inc., B. Braun Melsungen AG, Cook Medical, Inc., DJO LLC, G21 S.r.l., Heraeus Medical GmbH, Johnson & Johnson, Medacta International, Medtronic PLC, Normet Group, OSARTIS GmbH, Smith & Nephew PLC, Stryker Corporation, Tecres S.p.A., and Teknimed.

Market Segmentation & Coverage

This research report categorizes the Injectable Cement Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across High Viscosity Cements, Low Viscosity Cements, and Medium Viscosity Cements.
• Based on Application, market is studied across Pelvic Fractures and Periprosthetic Fractures.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing rate of minimally invasive surgeries
    • 5.1.1.2. High risk of bone defects among the geriatric population
    • 5.1.1.3. Growing government investments in the healthcare research
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability of injectable cement materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Advanced properties of bioactive calcium phosphate bone cement
    • 5.1.3.2. Development of new injectable cement materials
  • 5.1.4. Challenges
    • 5.1.4.1. Severe immune response and infections caused by injectable cement
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Injectable Cement Market, by Type

• 6.1. Introduction
• 6.2. High Viscosity Cements
• 6.3. Low Viscosity Cements
• 6.4. Medium Viscosity Cements

7. Injectable Cement Market, by Application

• 7.1. Introduction
• 7.2. Pelvic Fractures
• 7.3. Periprosthetic Fractures

8. Americas Injectable Cement Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Injectable Cement Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Injectable Cement Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Arthrex, Inc.
• 2. B. Braun Melsungen AG
• 3. Cook Medical, Inc.
• 4. DJO LLC
• 5. G21 S.r.l.
• 6. Heraeus Medical GmbH
• 7. Johnson & Johnson
• 8. Medacta International
• 9. Medtronic PLC
• 10. Normet Group
• 11. OSARTIS GmbH
• 12. Smith & Nephew PLC
• 13. Stryker Corporation
• 14. Tecres S.p.A.
• 15. Teknimed